NFE2L2 and thyroid gland carcinoma: The signaling of Nrf2 was also found to be activated in thyroid carcinomas, where it exerts a dual role, since, in addition to conferring protection against oxidative stress, it also promotes drug resistance to malignant cells [32,43].